Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Shock. Diagnosis and management.

M C Houston, W L Thompson, D Robertson

    Archives of Internal Medicine
    |July 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Clinical shock management has evolved, prioritizing volume replacement over pure vasoconstrictors. Experimental therapies like naloxone hydrochloride and corticosteroids show promise for improved shock syndrome treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Orthostatic intolerance in Behcet's disease.

    Autonomic neuroscience : basic & clinical·2001
    Same author

    Familial orthostatic tachycardia due to norepinephrine transporter deficiency.

    Annals of the New York Academy of Sciences·2001
    Same author

    The Ca(2+) status of the endoplasmic reticulum is altered by induction of calreticulin expression in transgenic plants.

    Plant physiology·2001
    Same author

    Can simultaneous inhibition of seedling growth and stimulation of rhizosphere bacterial populations provide evidence for phytotoxin transfer from plant residues in the bulk soil to the rhizosphere of sensitive species?

    Journal of chemical ecology·2001
    Same author

    Gene pill patents a surprise for gene therapy.

    Nature biotechnology·2001
    Same author

    Origin of the noradrenergic innervation of the superior olivary complex in the rat.

    Journal of chemical neuroanatomy·2001
    Same journal

    Elevated CK-MB With Normal Total Creatine Kinase Levels in Patients Undergoing Maintenance Hemodialysis-Reply.

    Archives of internal medicine·2017
    Same journal

    Occult Carbon Monoxide Poisoning-Reply.

    Archives of internal medicine·2017
    Same journal

    Acquired Immune Deficiency Syndrome-Reply.

    Archives of internal medicine·2017
    Same journal

    Heparin Side Effects-Reply.

    Archives of internal medicine·2017
    Same journal

    Humanizing primary care medicine begins with stress.

    Archives of internal medicine·2017
    Same journal

    Legend omitted and number misrepresented.

    Archives of internal medicine·2013
    See all related articles

    Area of Science:

    • Critical care medicine
    • Pharmacology
    • Pathophysiology

    Background:

    • Clinical shock presents with diverse causes and manifestations.
    • Therapeutic strategies are increasingly tailored to specific shock etiologies.
    • The role of vasoconstrictors has diminished in favor of initial volume resuscitation.

    Purpose of the Study:

    • To review the evolving landscape of clinical shock management.
    • To highlight the shift towards specific therapies.
    • To discuss the current and experimental therapeutic agents.

    Main Methods:

    • Literature review of recent investigations in clinical shock.
    • Analysis of therapeutic roles of vasoconstrictors and volume expansion.
    • Examination of experimental agents for shock management.

    Related Experiment Videos

    Main Results:

    • Volume replacement is the primary initial management for shock.
    • Pure vasoconstrictors now play a secondary therapeutic role.
    • Experimental agents including naloxone hydrochloride, corticosteroids, and others offer potential advancements.

    Conclusions:

    • Modern shock management emphasizes individualized and specific therapeutic approaches.
    • Volume resuscitation is the cornerstone of initial shock treatment.
    • Ongoing research into novel agents promises enhanced understanding and treatment of shock syndromes.